Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Pharmac stacks on workers with bigger remit

Pharmac stacks on workers after expanding in medical devices, vaccines

By Olivia Bascand

Feb. 3 (BusinessDesk) – Pharmac, which manages an annual drug-funding budget of more than $780 million, plans to extend a three-year hiring spree after expanding in medical devices, vaccines and hospital medicines.

The Pharmaceutical Management Agency will increase its workforce to about 130 from 110 currently, having added 70 workers in the past three years.

The state-funded body has taken on more floor space, hired an architect to oversee a revamp of its Wellington headquarters and put out a tender for IT advice that would allow staff to work remotely, according to a request for information posted on the government’s GETS tender website.

“Pharmac is undergoing a period of rapid growth, including a dramatic increase in staff numbers,” the body says in its tender notice.

Pharmac funded a record 42.2 million prescriptions last year, with 3.4 million New Zealanders getting subsidised medicines, also a record, according to its latest annual report.

In 2012, the government agreed to a plan for Pharmac to progressively expand its management and procurement of hospital devices and consumables, which cost District Health Boards some $880 million in the 2011 year and are rising faster than increases in the DHBs’ funding.

Pharmac tends to cop criticism from consumers in trying to squeeze the best possible health outcomes from the government’s health budget. Trying to meet the public’s growing demand for new medicines within a defined budget is “challenging,” the body says on its website.

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

At the same time, drug companies have criticised the centralised buying agency, saying it has stifled development of drugs in New Zealand, while being reluctant to fund high-cost medicines to treat rare diseases.

Pharmac has also reportedly featured in confidential negotiations over the Trans-Pacific Partnership Agreement, the first free trade agreement linking Asia, the Pacific and the Americas.

(BusinessDesk)

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
GenPro: General Practices Begin Issuing Clause 14 Notices

GenPro has been copied into a rising number of Clause 14 notices issued since the NZNO lodged its Primary Practice Pay Equity Claim against General Practice employers in December 2023.More

SPADA: Screen Industry Unites For Streaming Platform Regulation & Intellectual Property Protections

In an unprecedented international collaboration, representatives of screen producing organisations from around the world have released a joint statement.More

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.